Literature DB >> 22809102

Endoplasmic reticulum stress in nonalcoholic fatty liver disease.

Michael J Pagliassotti1.   

Abstract

The underlying causes of nonalcoholic fatty liver disease are unclear, although recent evidence has implicated the endoplasmic reticulum in both the development of steatosis and progression to nonalcoholic steatohepatitis. Disruption of endoplasmic reticulum homeostasis, often termed ER stress, has been observed in liver and adipose tissue of humans with nonalcoholic fatty liver disease and/or obesity. Importantly, the signaling pathway activated by disruption of endoplasmic reticulum homeostasis, the unfolded protein response, has been linked to lipid and membrane biosynthesis, insulin action, inflammation, and apoptosis. Therefore, understanding the mechanisms that disrupt endoplasmic reticulum homeostasis in nonalcoholic fatty liver disease and the role of the unfolded protein response in the broader context of chronic, metabolic diseases have become topics of intense investigation. The present review examines the endoplasmic reticulum and the unfolded protein response in the context of nonalcoholic fatty liver disease.

Entities:  

Mesh:

Year:  2012        PMID: 22809102     DOI: 10.1146/annurev-nutr-071811-150644

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  92 in total

1.  [Effects of sera of rats fed with Huganqingzhi tablets on endoplasmic reticulum stress in a HepG2 cell model of nonalcoholic fatty liver disease].

Authors:  Miaoting Yang; Zhijuan Chen; Chunxin Xiao; Waijiao Tang; Beijie Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-11-30

2.  Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model.

Authors:  Reilly T Enos; Kandy T Velázquez; Jamie L McClellan; Taryn L Cranford; Michael D Walla; E Angela Murphy
Journal:  Nutr Res       Date:  2015-04-11       Impact factor: 3.315

3.  Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.

Authors:  Ming Tong; Lisa Longato; Teresa Ramirez; Valerie Zabala; Jack R Wands; Suzanne M de la Monte
Journal:  Int J Exp Pathol       Date:  2013-10-29       Impact factor: 1.925

Review 4.  Endoplasmic reticulum stress as the basis of obesity and metabolic diseases: focus on adipose tissue, liver, and pancreas.

Authors:  Aline Fernandes-da-Silva; Carolline Santos Miranda; Daiana Araujo Santana-Oliveira; Brenda Oliveira-Cordeiro; Camilla Rangel-Azevedo; Flávia Maria Silva-Veiga; Fabiane Ferreira Martins; Vanessa Souza-Mello
Journal:  Eur J Nutr       Date:  2021-03-19       Impact factor: 5.614

Review 5.  p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.

Authors:  Koji Taniguchi; Shinichiro Yamachika; Feng He; Michael Karin
Journal:  FEBS Lett       Date:  2016-08-06       Impact factor: 4.124

6.  SphK1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes.

Authors:  Tuoyu Geng; Alton Sutter; Michael D Harland; Brittany A Law; Jessica S Ross; David Lewin; Arun Palanisamy; Sarah B Russo; Kenneth D Chavin; L Ashley Cowart
Journal:  J Lipid Res       Date:  2015-10-19       Impact factor: 5.922

7.  Astragaloside IV attenuates free fatty acid-induced ER stress and lipid accumulation in hepatocytes via AMPK activation.

Authors:  Bing Zhou; Dan-Li Zhou; Xiao-Hong Wei; Rong-Yu Zhong; Jie Xu; Liao Sun
Journal:  Acta Pharmacol Sin       Date:  2017-03-27       Impact factor: 6.150

8.  Thioesterase-mediated control of cellular calcium homeostasis enables hepatic ER stress.

Authors:  Baran A Ersoy; Kristal M Maner-Smith; Yingxia Li; Ipek Alpertunga; David E Cohen
Journal:  J Clin Invest       Date:  2017-11-20       Impact factor: 14.808

9.  The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.

Authors:  April D Lake; Petr Novak; Rhiannon N Hardwick; Brieanna Flores-Keown; Fei Zhao; Walter T Klimecki; Nathan J Cherrington
Journal:  Toxicol Sci       Date:  2013-10-04       Impact factor: 4.849

Review 10.  Fatty acid-regulated transcription factors in the liver.

Authors:  Donald B Jump; Sasmita Tripathy; Christopher M Depner
Journal:  Annu Rev Nutr       Date:  2013-03-22       Impact factor: 11.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.